Walleye Capital LLC Evogene Ltd. Transaction History

Walleye Capital LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.47 - $0.88 $78,779 - $147,501	-167,615 Reduced 32.41%	349,477 $293,000
Q3 2023 Nov 14, 2023	BUY	$0.58 - $1.41 $299,913 - $729,099	517,092 New	517,092 $305,000
Q2 2022 Aug 08, 2022	SELL	$0.75 - $1.33 $8,503 - $15,079	-11,338 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.09 - $1.83 $14,934 - $25,072	-13,701 Reduced 54.72%	11,338 $15,000
Q4 2021 Mar 03, 2022	BUY	$1.63 - $2.83 $40,813 - $70,860	25,039 New	25,039 $41,000

Q3 2021 Nov 15, 2021	SELL	$2.45 - $3.45 $46,491 - $65,467	-18,976 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$3.3 - $5.02 $6,679 - $10,160	-2,024 Reduced 9.64%	18,976 $65,000
Q1 2021 May 17, 2021	BUY	$4.29 - $9.94 $90,090 - $208,740	21,000 New	21,000 $106,000

4.08M

23K

Ticker EVGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,202,000
Market Cap $26M
Description
Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.